DK1016711T3 - Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus - Google Patents

Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus

Info

Publication number
DK1016711T3
DK1016711T3 DK99403194T DK99403194T DK1016711T3 DK 1016711 T3 DK1016711 T3 DK 1016711T3 DK 99403194 T DK99403194 T DK 99403194T DK 99403194 T DK99403194 T DK 99403194T DK 1016711 T3 DK1016711 T3 DK 1016711T3
Authority
DK
Denmark
Prior art keywords
enveloped viruses
virus preparation
viral preparation
preparation
adenovirus virus
Prior art date
Application number
DK99403194T
Other languages
English (en)
Inventor
David Gaillac
Michel Koehl
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK1016711T3 publication Critical patent/DK1016711T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361—Methods of inactivation or attenuation
    • C12N2710/10363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK99403194T 1998-12-21 1999-12-17 Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus DK1016711T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816147A FR2787465A1 (fr) 1998-12-21 1998-12-21 Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
EP19990403194 EP1016711B1 (fr) 1998-12-21 1999-12-17 Procédé d'inactivation de virus enveloppés dans une préparation virale d'adénovirus

Publications (1)

Publication Number Publication Date
DK1016711T3 true DK1016711T3 (da) 2005-03-07

Family

ID=9534248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99403194T DK1016711T3 (da) 1998-12-21 1999-12-17 Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus

Country Status (11)

Country Link
US (2) US7026154B1 (da)
EP (1) EP1016711B1 (da)
JP (1) JP4459353B2 (da)
AT (1) ATE280823T1 (da)
AU (1) AU769121B2 (da)
CA (1) CA2292922C (da)
DE (1) DE69921435T2 (da)
DK (1) DK1016711T3 (da)
ES (1) ES2230820T3 (da)
FR (1) FR2787465A1 (da)
PT (1) PT1016711E (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003014338A1 (ja) * 2001-08-02 2004-11-25 アンジェスＭｇ株式会社 不活性化ウイルスエンベロープの製造方法
JP5322252B2 (ja) * 2001-12-20 2013-10-23 バヴァリアン・ノルディック・アクティーゼルスカブ 感染細胞からのポックスウイルスの採取および精製法
DK1648931T3 (da) 2003-07-21 2011-03-07 Transgene Sa Multifunktionelle cytokiner
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
US20060130159A1 (en) * 2004-12-09 2006-06-15 Nick Masiello Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
WO2008092854A2 (en) 2007-01-30 2008-08-07 Transgene S.A. Papillomavirus e2 polypeptide used for vaccination
EP2382474B1 (en) 2009-01-20 2015-03-04 Transgene SA Soluble icam-1 as biomarker for prediction of therapeutic response
SG2014014021A (en) 2009-03-24 2014-07-30 Transgene Sa Biomarker for monitoring patients
HRP20140262T1 (hr) 2009-04-17 2014-04-25 Transgene Sa Biomarker za praä†enje pacijenata
AU2010270313B2 (en) 2009-07-10 2014-05-22 Transgene Sa Biomarker for selecting patients and related methods
TWI555531B (zh) 2009-08-07 2016-11-01 傳斯堅公司 用以治療ｂ型肝炎病毒（ｈｂｖ）感染之組成物
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
KR101997543B1 (ko) 2010-07-30 2019-07-09 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
JP6430949B2 (ja) 2012-10-23 2018-11-28 エモリー ユニバーシティ Ｇｍ−ｃｓｆとｉｌ−４のコンジュゲート、組成物、ならびにそれに関連する方法
ES2877563T3 (es) 2014-09-02 2021-11-17 Emd Millipore Corp Medios de cromotografía que comprenden conjuntos porosos discretos de nanofibrillas
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber
ES3011733T3 (en) 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007545A1 (en) * 1989-01-13 1990-07-13 Yahiro Uemura Production method for protein-containing composition
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US6281010B1 (en) * 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
DE19623293C2 (de) * 1996-06-11 1998-10-22 Biotest Pharma Gmbh Nicht-immunogene Faktor VIII-enthaltende Zusammensetzung und ein Verfahren zu ihrer Herstellung
ATE477320T1 (de) * 1996-12-13 2010-08-15 Schering Corp Methoden zur virus-reinigung
DE19709186C2 (de) * 1997-03-06 1999-10-14 Medigene Ag Filtrationsverfahren zur Trennung von Viren

Also Published As

Publication number Publication date
EP1016711B1 (fr) 2004-10-27
ES2230820T3 (es) 2005-05-01
US7378265B2 (en) 2008-05-27
EP1016711A1 (fr) 2000-07-05
AU6535899A (en) 2000-06-22
DE69921435T2 (de) 2006-03-02
FR2787465A1 (fr) 2000-06-23
CA2292922C (fr) 2011-05-31
JP2000201673A (ja) 2000-07-25
US20060166345A1 (en) 2006-07-27
CA2292922A1 (fr) 2000-06-21
DE69921435D1 (de) 2004-12-02
AU769121B2 (en) 2004-01-15
US7026154B1 (en) 2006-04-11
ATE280823T1 (de) 2004-11-15
JP4459353B2 (ja) 2010-04-28
PT1016711E (pt) 2005-02-28

Similar Documents

Publication Publication Date Title
DK1016711T3 (da) Fremgangsmåde til inaktivering af kappeklædte virus i et viruspræparat med adenovirus
ES8307500A1 (es) "metodo para inactivar los virus infecciosos contenidos en una composicion enzimatica hemocoagulante".
WO2000034444A3 (en) Method and composition for preserving viruses
MY141641A (en) Compositions comprising viruses and methods for concentrating virus preparations
EP1964569A3 (en) 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
DE69232649D1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
ATE110412T1 (de) Translation von mrna.
DK0689447T3 (da) Cytopatiske vira til behandling af og profylakse for neoplasia
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
NO20091761L (no) Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav
ATE335810T1 (de) Verfahren zur inaktivierung von lipidumhüllten viren
DK437988A (da) Fremgangsmaade til rensning af hepatitis a vironer
ATE149355T1 (de) Verfahren zur inaktivierung von prionen
DE69637181D1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
PL330407A1 (en) Substituted cyclopentane compounds useful as neuraminidaze inhibitors
DK57284A (da) Fremgangsmaade til inaktivering af et lipidvirus
DK1149910T3 (da) Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
DK0988302T3 (da) Benzonaphthyridiner
ATE186836T1 (de) Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen
FI953756A7 (fi) Menetelmä lipidivaipattomien virusten inaktivoimiseksi
NO933986L (no) Fremgangsmåte for kvantitativ rensing av glykolipider
EP0909172A4 (en) METHODS AND COMPOSITIONS FOR TREATING URINARY INCONTINENCE WITH ENANTIOMERIC ENRICHED (R, s) -GLYCOPYRROLATE
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
ATE150086T1 (de) Cdns-sequenz und detektion des hepatitis c-virus
JPS5395961A (en) Tetrahydrophthalimide derivatives process for their preparation and herbicides containing the same